展期：2024-5-27 ~ 2024-6-3

試用期間：即日起至 2024/12/31 日止
本次提供「Wiley 西文電子百科」、「HyRead 中文電子書」、「iRead ebooks 華藝電子書」及「udn 讀書館中文電子書」四種電子書平台做為選購試用

皮膚老化常見的結構性變化包括膠原蛋白流失、彈性組織減少、真皮-表皮界面變平與表皮層變薄。為了修復這些結構性損傷，必須全面作用於表皮和真皮層。許多美容程序旨在活化皮膚天然的傷口修復過程，涉及表皮和真皮的雙重作用。

繼續閱讀...

講題：Elucidating retrograde Golgi transport and nuclear targeting of HPV during entryion
主講者：Dr. Tai-Ting Woo (Postdoctoral research fellow, Department of Cell and Developmental Biology, University of Michigan Medical School, USA)
時間：2024-05-28 11:00 - 12:00
地點：中央研究院分子生物研究所1F演講廳

講題：A Journey in Exploring the Mystery of HCV Diabetogenesis
主講者：余明隆 副校長 (國立中山大學)
時間：2024-05-29 10:30 - 12:00
地點：基因體研究中心一樓演講廳

講題：Molecular mechanisms underpinning the regulation of an atypical small Ras-like GTPase “MglA” from Myxococcus xanthus
主講者：Dr. Céline Dinet (Post-doctoral Researcher, Université Aix-Marseille, France)
時間：2024-05-29 15:00 - 16:00
地點：中央研究院分子生物研究所1F演講廳

講題：Agent-based simulations to explore the transitions in the life cycle of the predatory bacterium Myxococcus xanthus
主講者：Dr. Jean-Baptiste Saulnier (Post-doctoral Fellow, Laboratoire de Chimie Bact´erienne, Marseille, France)
時間：2024-05-29 16:00 - 17:00
地點：中央研究院分子生物研究所1F演講廳

講題：New Insights into Starch Biosynthesis: How Plants Control Starch Granule Initiation and its Crystallization
主講者：Dr. Samuel Zeeman (Professor, Department of Biology, ETH Zürich, Switzerland)/ Dr. Simon Bull (Group Leader/Lecturer, Department of Environmental Systems Science, ETH Zürich, Switzerland)
時間：2024-05-30 10:00 - 12:00
地點：中央研究院植物暨微生物學研究所農業科技大樓 A134演講廳

講題：How do plants respond to light and cope with stress? Discovering mechanisms in response to light-stress crosstalk for resilient plant generation
主講者：鄭梅君助理教授(國立臺灣大學生化科技學系)
時間：2024-06-03 11:00 - 12:00
地點：中央研究院植物暨微生物學研究所農業科技大樓 A134演講廳

講題：Engineered Nanobodies as Tools to Visualize and Direct Antigen-Specific Tolerance
主講者：Dr. Novalia Pishesha (Harvard Medical School)
時間：2024-06-03 11:00 - 12:00
地點：生醫所地下室B1B演講廳

講題：Protein glycosylation and outer membrane vesicles in Helicobacter pylori infection and host-pathogen interactions
主講者：高茂傑教授 (國立清華大學)
時間：2024-06-04 11:00 - 12:00
地點：生化所209研討室

講題：Enhancing brain health through dietary restriction: investigating the role of the microbiota-gut-brain axis
主講者：王培育 教授 (國立臺灣大學腦與心智科學研究所)
時間：2024-06-05 11:00 - 12:00
地點：跨領域大樓一樓演講廳

講題：Exploring the Intricate Cellulose Synthase Complex alongside the Deceptively Simple Glucan Chain
主講者：Dr. Ying Gu (Professor/Director of Graduate Studies/Associate Department Head, Department of Biochemistry and Molecular Biology, The Pennsylvania State University)
時間：2024-06-05 11:00 - 12:00
地點：中央研究院植物暨微生物學研究所農業科技大樓 A134演講廳

講題：Caffeine and Alzheimer’s Disease: the neuroglial impact of adenosine receptors
主講者：David Blum教授 (Inserm, Lille Neuroscience & Cognition, France)
時間：2024-06-06 11:00 - 12:00
地點：跨領域大樓一樓演講廳

時間：2024年8月12-16日
地點：中研院基因體研究中心一樓演講廳

Certain bacteria demonstrate the ability to target and colonize the tumor microenvironment, a characteristic that positions them as innovative carriers for delivering various therapeutic agents in cancer therapy.

繼續閱讀...

Essential tremor (ET) is the most prevalent movement disorder, characterized primarily by action tremor, an involuntary rhythmic movement with a specific frequency.

繼續閱讀...

The causative pathogen of COVID-19, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), utilizes the receptor-binding domain (RBD) of the spike protein to bind to human receptor angiotensin-converting enzyme 2 (ACE2).

繼續閱讀...

Identifcation of cancer vulnerabilities through understanding the mechanism of ALT telomere maintenance Orphan nuclear receptors (NRs), such as COUP-TF1, COUP-TF2, EAR2, TR2, and TR4, are implicated in telomerase-negative cancers that maintain their telomeres through the alternative lengthening of telomeres (ALT) mechanism. However, how the telomeric association of orphan NRs is involved in ALT activation remains unclear.

繼續閱讀...

Since its emergence, SARS-CoV-2 has been continuously evolving, hampering the effectiveness of current vaccines against COVID-19. mAbs can be used to treat patients at risk of severe COVID-19.

Since its emergence, SARS-CoV-2 has been continuously evolving, hampering the effectiveness of current vaccines against COVID-19. mAbs can be used to treat patients at risk of severe COVID-19. Thus, the development of broadly protective mAbs and an understanding of the underlying protective mechanisms are of great importance.

繼續閱讀...